CD34 Is Required for Infiltration of Eosinophils into the Colon and Pathology Associated with DSS-Induced Ulcerative Colitis
- 30 September 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 177 (3), 1244-1254
- https://doi.org/10.2353/ajpath.2010.100191
Abstract
No abstract availableFunding Information
- operating grants from the CIHR (#MIF-79631 and #M0P-84545)
- AllerGen Network Centre of Excellence (3.14)
This publication has 41 references indexed in Scilit:
- Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesisNature, 2010
- Treatment with a Novel Chemokine-Binding Protein or Eosinophil Lineage-Ablation Protects Mice from Experimental ColitisThe American Journal of Pathology, 2009
- Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced ColitisInflammatory Bowel Diseases, 2009
- CD34 facilitates the development of allergic asthmaBlood, 2007
- ICAM-1-dependent pathways regulate colonic eosinophilic inflammationJournal of Leukocyte Biology, 2006
- Systemic administration of the chemokine macrophage inflammatory protein 1 exacerbates inflammatory bowel disease in a mouse modelGut, 2005
- Eotaxin-2 regulates newly produced and CD34+ airway eosinophils after allergen exposureJournal of Allergy and Clinical Immunology, 2004
- Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient miceGenes & Immunity, 2000
- Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel diseaseHistopathology, 1996
- IL-5-Deficient Mice Have a Developmental Defect in CD5+ B-1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell ResponsesImmunity, 1996